Phospho-AKT levels were indeed significantly decreased following ADAM17 knockdown in both RB cell lines investigated (Figure 9a,c,e,g), whereas ADAM10 knockdown did not influence the AKT phosphorylation status of the cells (Figure 9b,f). The gene discussed is ADAM17; the disease is retinoblastoma.